Comparison between the outcomes of combined phaco/trabeculectomy by cataract incision site
PDF

How to Cite

Tous, H. M., & Nevárez, J. (2007). Comparison between the outcomes of combined phaco/trabeculectomy by cataract incision site. Puerto Rico Health Sciences Journal, 26(1). Retrieved from https://prhsj.rcm.upr.edu/index.php/prhsj/article/view/263

Abstract

Purpose: To analyze and compare the main outcomes of two techniques of combined surgery; mitomycin enhanced trabeculectomy combined with phacoemulsification and intraocular lens implantation through a single incision versus a two incisions approach. Patients and Methods: The authors retrospectively reviewed one surgeon’s consecutive 395 combined phacoemulsification/trabeculectomy surgeries. Patients were divided into two groups, those who underwent phacoemulsification and intraocular lens implantation through one incision (Phaco 1) and the other through two incisions (Phaco 2), both combined with trabeculectomy. Analysis of postoperative visual acuity, intraocular pressure, number of glaucoma medications, postoperative adverse events and additional procedures required, was done. Minimum follow-up was 12 months with an average of 49.2 months. Results: There was a significant difference (p = 0.0237) between the groups in terms of visual acuity improvement rate. By the end of the follow up period, both techniques were equally effective in reducing IOPs by an average of 8.1 mmHg. Postoperative pressure spikes occurred in 9% versus 11% (p = 0.6838) of the eyes. No significant difference (63% Phaco 1 versus 69% Phaco 2, p = 0.3230) between the two groups in terms of glaucoma medication reduction was found. There was no significant difference (p = 0.1181), in the total postoperative complications between the two groups (60% Phaco 1 vs. 51% Phaco 2), as well as in the total number of eyes which required further interventions (60% versus 68%, p = 0.2223). Conclusion: Combined phacoemulsification/ trabeculectomy using either a single or a two site approach, are equally effective in treating glaucoma patients with cataracts.
PDF
Authors who publish with this journal agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).